Literature DB >> 10559329

Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines.

H W Chen1, C H Pan, M Y Liau, R Jou, C J Tsai, H J Wu, Y L Lin, M H Tao.   

Abstract

In this study, we evaluated the relative role of the structural and nonstructural proteins of the Japanese encephalitis virus (JEV) in inducing protective immunities and compared the results with those induced by the inactivated JEV vaccine. Several inbred and outbred mouse strains immunized with a plasmid (pE) encoding the JEV envelope protein elicited a high level of protection against a lethal JEV challenge similar to that achieved by the inactivated vaccine, whereas all the other genes tested, including those encoding the capsid protein and the nonstructural proteins NS1-2A, NS3, and NS5, were ineffective. Moreover, plasmid pE delivered by intramuscular or gene gun injections produced much stronger and longer-lasting JEV envelope-specific antibody responses than immunization of mice with the inactivated JEV vaccine did. Interestingly, intramuscular immunization of plasmid pE generated high-avidity antienvelope antibodies predominated by the immunoglobulin G2a (IgG2a) isotype similar to a sublethal live virus immunization, while gene gun DNA immunization and inactivated JEV vaccination produced antienvelope antibodies of significantly lower avidity accompanied by a higher IgG1-to-IgG2a ratio. Taken together, these results demonstrate that the JEV envelope protein represents the most critical antigen in providing protective immunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559329      PMCID: PMC113066     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Heterogeneity of cytokine secretion patterns and functions of helper T cells.

Authors:  T R Mosmann; R L Coffman
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

Review 2.  Genetic vaccines: strategies for optimization.

Authors:  G Gregoriadis
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

3.  Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays.

Authors:  M E Devey; K Bleasdale; S Lee; S Rath
Journal:  J Immunol Methods       Date:  1988-01-21       Impact factor: 2.303

4.  Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release.

Authors:  G Wengler; G Wengler
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.

Authors:  J Kimura-Kuroda; K Yasui
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

6.  Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children.

Authors:  Y Y Xin; Z G Ming; G Y Peng; A Jian; L H Min
Journal:  Am J Trop Med Hyg       Date:  1988-08       Impact factor: 2.345

7.  Protection against Japanese encephalitis by inactivated vaccines.

Authors:  C H Hoke; A Nisalak; N Sangawhipa; S Jatanasen; T Laorakapongse; B L Innis; S Kotchasenee; J B Gingrich; J Latendresse; K Fukai
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

8.  Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.

Authors:  P W Mason; J M Dalrymple; M K Gentry; J M McCown; C H Hoke; D S Burke; M J Fournier; T L Mason
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

9.  Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.

Authors:  J I Sin; J J Kim; K E Ugen; R B Ciccarelli; T J Higgins; D B Weiner
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

10.  Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses.

Authors:  K R Porter; T J Kochel; S J Wu; K Raviprakash; I Phillips; C G Hayes
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

View more
  21 in total

1.  Expression of domain III of the envelope protein from GP-78: a Japanese encephalitis virus.

Authors:  Sahil Kulkarni; Sandeepan Mukherjee; Krishna Mohan Padmanabha Das; Kaushiki Prabhudesai; Nupur Deshpande; Sushant Karnik; Abhay S Chowdhary; Usha Padmanabhan
Journal:  Virusdisease       Date:  2017-05-25

2.  Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.

Authors:  A V Timofeev; V M Butenko; J R Stephenson
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

3.  Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.

Authors:  Judith H Aberle; Stephan W Aberle; Regina M Kofler; Christian W Mandl
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis.

Authors:  Mark P Zanin; Diane E Webster; Steven L Wesselingh
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

5.  Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses.

Authors:  C H Pan; H W Chen; H W Huang; M H Tao
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.

Authors:  Shigefumi Okamoto; Hironori Yoshii; Masaaki Matsuura; Asato Kojima; Toyokazu Ishikawa; Takami Akagi; Mitsuru Akashi; Michiaki Takahashi; Koichi Yamanishi; Yasuko Mori
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

7.  DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

Authors:  J W Hooper; D M Custer; E Thompson; C S Schmaljohn
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine.

Authors:  Asato Kojima; Atsushi Yasuda; Hideki Asanuma; Toyokazu Ishikawa; Akihisa Takamizawa; Kotaro Yasui; Takeshi Kurata
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.

Authors:  Zijiang Zhao; Takaji Wakita; Kotaro Yasui
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 10.  Development of a recombinant vaccine against Japanese encephalitis.

Authors:  Rupinderjeet Kaur; Sudhanshu Vrati
Journal:  J Neurovirol       Date:  2003-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.